Overview

NB-001 Treatment of Recurrent Herpes Labialis

Status:
Unknown status

Trial end date:
2013-07-01

Target enrollment:

Participant gender:

Summary

This is a study to test the hypothesis that time to healing of a cold sore will be lower in the active treatment arm of the study when compared to the vehicle (placebo). Subjects with a history of cold sores will be enrolled and administered active treatment or placebo in a blinded manner. Subjects will then be followed to assess time to healing.

Phase:

Phase 3

Details

Lead Sponsor:

NanoBio Corporation

Treatments:

5- ((2- (6- Amino- 9H- purin- 9- yl) ethyl) amino) - 1- pentanol
5-((2-(6-Amino-9H-purin-9-yl) ethyl) amino)-1-pentanol